In vivo imaging of Bcr-Abl overexpressing tumors with a radiolabeled imatinib analog as an imaging surrogate for imatinib.
about
Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET ImagingTheragnostic imaging using radiolabeled antibodies and tyrosine kinase inhibitorsPET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET.Molecular imaging for personalized cancer care.Effective Concentration of a Multikinase Inhibitor within Bone Marrow Correlates with In Vitro Cell Killing in Therapy-Resistant Chronic Myeloid Leukemia.Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level.
P2860
In vivo imaging of Bcr-Abl overexpressing tumors with a radiolabeled imatinib analog as an imaging surrogate for imatinib.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
In vivo imaging of Bcr-Abl ove ...... maging surrogate for imatinib.
@ast
In vivo imaging of Bcr-Abl ove ...... maging surrogate for imatinib.
@en
type
label
In vivo imaging of Bcr-Abl ove ...... maging surrogate for imatinib.
@ast
In vivo imaging of Bcr-Abl ove ...... maging surrogate for imatinib.
@en
prefLabel
In vivo imaging of Bcr-Abl ove ...... maging surrogate for imatinib.
@ast
In vivo imaging of Bcr-Abl ove ...... maging surrogate for imatinib.
@en
P2093
P2860
P1476
In vivo imaging of Bcr-Abl ove ...... imaging surrogate for imatinib
@en
P2093
Athanasios P Glekas
Blesida Punzalan
Nahida Khan
Peter Smith-Jones
Steven M Larson
P2860
P304
P356
10.2967/JNUMED.110.085050
P407
P577
2011-07-15T00:00:00Z